NCT07369505 2026-01-27Sapu003 in Advanced mTOR-sensitive Solid TumorsSAPU NANO (US) LLCPhase 1 Recruiting27 enrolled
NCT07348211 2026-01-23SIM0610-101Jiangsu Simcere Pharmaceutical Co., Ltd.Phase 1 Recruiting260 enrolled
NCT04676633 2024-03-19Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard TherapySirnaomicsPhase 1 Completed5 enrolled